share_log

科濟藥業-B:翌日披露報表

CARSGEN-B: Next Day Disclosure Return

Hong Kong Stock Exchange ·  May 31 10:16
Summary by Moomoo AI
科濟藥業-B(02171.HK)於2024年5月31日進行了股份購回活動,根據香港聯合交易所有限公司證券上市規則披露。該公司購回了400,000股普通股,佔其於購回前已發行股份的0.069%。購回的每股價格為6.87港元,總共耗資2,748,000港元。購回後,科濟藥業的已發行股本維持在575,643,915股。公司確認,此次股份購回已獲董事會批准,並符合所有相關法律規定及上市規則的要求。
科濟藥業-B(02171.HK)於2024年5月31日進行了股份購回活動,根據香港聯合交易所有限公司證券上市規則披露。該公司購回了400,000股普通股,佔其於購回前已發行股份的0.069%。購回的每股價格為6.87港元,總共耗資2,748,000港元。購回後,科濟藥業的已發行股本維持在575,643,915股。公司確認,此次股份購回已獲董事會批准,並符合所有相關法律規定及上市規則的要求。
KOCHI PHARMACEUTICAL-B (02171.HK) CONDUCTED A SHARE REPURCHASE ACTIVITY ON MAY 31, 2024, ACCORDING TO THE LISTING RULES DISCLOSED BY THE STOCK EXCHANGE OF HONG KONG STOCK EXCHANGE LIMITED. The company repurchased 400,000 shares of common stock, representing 0.069% of its shares issued prior to the repurchase. The buyback was priced at HK$6.87 per share, with a total cost of HK$2,748,000. After the repurchase, the issued share capital of Kozai Pharmaceuticals remained at 575,643,915 shares. The Company confirms that this share repurchase has been approved by the Board of Directors and complies with all relevant legal requirements and listing rules.
KOCHI PHARMACEUTICAL-B (02171.HK) CONDUCTED A SHARE REPURCHASE ACTIVITY ON MAY 31, 2024, ACCORDING TO THE LISTING RULES DISCLOSED BY THE STOCK EXCHANGE OF HONG KONG STOCK EXCHANGE LIMITED. The company repurchased 400,000 shares of common stock, representing 0.069% of its shares issued prior to the repurchase. The buyback was priced at HK$6.87 per share, with a total cost of HK$2,748,000. After the repurchase, the issued share capital of Kozai Pharmaceuticals remained at 575,643,915 shares. The Company confirms that this share repurchase has been approved by the Board of Directors and complies with all relevant legal requirements and listing rules.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more